Harmony Biosciences Holdings, Inc. HRMY
NASDAQ · United States · Health Technology
$39.57+0.31 (+0.79%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-04 | 1.28 | 0.96 | +33.8% | $261.28M | +4.2% | +7.4%$35.60→$38.24 |
| Q1 2026 | 2026-05-07 | 0.55 | 0.76 | -27.6% | — | — | -5.5%$32.78→$30.99 |
| Q4 2025 | 2026-02-24 | 0.57 | 1.07 | -46.7% | — | — | +4.9%$26.87→$28.19 |
| Q3 2025 | 2025-11-04 | 0.87 | 0.92 | -5.4% | — | — | +6.9%$29.33→$31.35 |
| Q4 2024 | 2025-02-25 | 1.08 | 0.82 | +31.7% | — | — | — |
| Q3 2024 | 2024-10-29 | 1.03 | 0.88 | +17.0% | — | — | — |
| Q1 2024 | 2024-04-30 | 0.88 | 0.69 | +27.5% | — | — | — |
| Q4 2023 | 2024-02-22 | 0.73 | 0.91 | -19.8% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.